Non-Addictive Cannabis Solution for Chronic Back Pain Revealed in Germany

munich - Exilby, a new cannabis-based pain reliever as strong as opioids but non-addictive, presents hope for chronic pain sufferers in Germany.

Exilby: A New Non-Addictive Pain Reliever

Exilby, a cannabis-based medicine developed by Vertanical in Munich, is set to offer significant pain relief for chronic back pain sufferers without the addictive properties of opioids.

Key Points:

• Exilby presented by Vertanical, awaiting approval in Germany.
• Offers pain reduction similar to opioids but without addiction.
• Addresses sleep support and depression often experienced by chronic pain patients.
• No significant side effects reported, minimal drowsiness and dizziness possible initially.

Vertanical's CEO, Clemens Fischer, emphasizes Exilby's advantages over traditional opioids, highlighting its ability to combat depression and support better sleep while remaining non-addictive.

If approved, Exilby will be the first of its kind in the pain relief market, with plans to expand to the European and global markets.